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Introduction 
Life style-related diseases are the highest cause of death globally and cardiovascular 
disease is one of them that directly related to high blood pressure. Metabolic syndrome is a 
condition of cardiovascular risk factors like as hypertension, hyperglycemia, insulin resistance, 
excessive visceral fat storage, dyslipidemia, oxidative stress and chronic inflammation. The 
prevalence of metabolic syndrome and its impact on public health have increased attention in 
recent years. Certain dietary components and many plant based functional foods help to 
prevent or moderate metabolic syndrome by assisting the body homeostasis mechanism. 
Processed foods with antihypertensive effect such as soybean, banana, Chinese celery, grape 
fruit, olive oil, olive leaf, pumpkin, green tea and seaweed are effective against metabolic 
syndrome. Functional food is getting new momentum in response to maintain better health 
condition in both developed and developing countries. The term “Functional Food” originated in 
Japan 1980s and migrated to EU and United States. In general, functional food is a modified 
food that claims to improve health or well-being by providing benefit beyond that of the 
traditional nutrients contribution. Recent studies developed a concept of functional food as a 
convenient and inexpensive remedy to prevent chronic health problems.  Recently functional 
food defines as natural or processed foods that contain biologically-active compounds, an 
effective nontoxic amount, and provide a clinically proven and documented health benefit for 
the prevention, management, or treatment of life style-related diseases. Regarding this point of 
view, many plant based food supplements reinforced the list of functional foods. Previously, our 
laboratory found that proteinase-treated soymilk was better than original soymilk to inhibit the 
angiotensin I-converting enzyme (ACE) in vitro and dietary rice bran fraction improved 
hypertension, glucose and lipid metabolisms in stroke prone spontaneously hypertensive rat 
(SHRSP).  
In the present study, two types of functional food candidates, processed (proteinase- 
treated) soymilk and fermented rice bran, that were produced from original soymilk and rice 
bran, respectively, were investigated whether processed soymilk and fermented rice bran were 
effective in the prevention or improvement of metabolic syndrome or effective against 
cardiovascular risk factors in genetic animal model of life style-related diseases. 
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 Chapter 1 
Effect of processed soymilk on cardiovascular risk factors in genetic animal model of 
spontaneously hypertensive rat (SHR).    
Metabolic syndrome is now considered one of the world’s leading public health problem. 
Bioactive peptides deriving from milk proteins may play an important role in the prevention and 
treatment of metabolic syndrome via several mechanisms. Processed soymilk (PSM) was 
produced from original soymilk by treatment with a commercially available proteinase PROTIN 
SD-NY 10 (0.05% w/w) to generate inhibitory peptides against the angiotensin I-converting 
enzyme (ACE). Eight novel ACE inhibitory peptides and higher ACE inhibitory activity of PSM 
were determined in cell free assay (Tomatsu et.al. 2013). In order to determine whether the in 
vitro effect of PSM corresponds to a decrease in blood pressure in vivo, present experiment was 
conducted to investigate PSM’s potential antihypertensive effect on spontaneously 
hypertensive rats (SHR). First, single oral administration at doses of 0.016, 0.167 and 0.583 
ml/2ml/kg body weight was done to investigate which dose would be effective against blood 
pressure. In Figure 1, PSM at doses of 0.167 and 0.583 ml/2ml/kg body weight significantly 
decreased systolic blood pressure in SHR compared to control (non-processed soymilk). 
Repeated administration of PSM once a day for consecutive 3 weeks at doses of 0.167 and 
0.583 ml/2ml/kg body weight significantly reduced systolic, diastolic and mean blood pressure 
in SHR compared to control (Figure 2). After repeated PSM administration, its inhibitory activity 
against serum ACE was significantly higher compared to the control (Figure 3 A). Serum levels of 
the angiotensin II (product of ACE) was significantly lower than control (Figure 3 B). Furthermore, 
PSM administration increased serum nitric oxide level but no effect on thoracic aorta (Figure 3 C 
and D). Serum glucose, liver lipid profiles and serum activities of aspartate aminotransferase 
and alanine aminotransferase were similar in PSM groups compared to control (Figure 4). Food 
intake, water intake, body weight and heart rate were unchanged (Table 1). Finally a 
tetrapeptide (FFYY) that identified as an active peptide (40 µg/mL) in PSM (Shimakage 
et.al.2013) was investigated its antihypertensive effect on SHR. Single oral administration of 
synthetic FFYY significantly reduced both systolic and diastolic blood pressure at a dose of 80 
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µg/kg body weight compared to control (captopril as a positive control 7 mg/kg body weight) 
group (Figure 5). Thus, PSM may be considered as a functional food that can ameliorate 
cardiovascular risk factors related to hypertension without causing adverse side effects. 
 
 
Chapter 2 
Effect of fermented rice bran on metabolic syndrome in genetic animal model of stroke prone 
spontaneously hypertensive rat (SHRSP).  
Disease fighting properties of rice bran has advanced the development of rice bran for 
human use as a functional food and dietary supplements. To be more applicable of rice bran 
against metabolic syndrome, several techniques including fermentation have been used in 
biotechnological applications to enhance nutrition. Several studies have shown that the rice 
bran, fermented with Saccharomyces cerevisiae, Aspergillus oryzae, and Issatchenkia orientalis, 
has health beneficial effect. However, few studies to date have examined the effect of 
fermented rice bran (FRB) on the metabolic syndrome in SHRSP. In this study, the metabolic 
improvement effects of rice bran, fermented with Aspergillus kawachii and Lactobacillus, have 
been investigated in genetic animal model of metabolic syndrome. The fermented rice bran 
(FRB) was produced from rice bran (mixture of rice bran and rice powder 2:1 is called Non-FRB) 
by conventional fermentation process using Aspergillus kawachii (0.1% w/w) and lactobacillus 
(0.01% w/w) treatment. We investigated FRB’s potential effect on metabolic syndrome using 
stroke prone spontaneously hypertensive rat (SHRSP). Single oral administration of FRB and 
Non-FRB at a dose of 2 g/kg body weight significantly decreased systolic blood pressure in 
SHRSP compared to control. Single oral administration also reduced serum glucose, insulin and 
hepatic glucose-6-phosphatase, catalytic subunit (G6PC) mRNA expression (Figure 6). Chronic 
supplementation for 4 weeks of FRB and Non-FRB (Table 2, experimental diet) significantly 
reduced food intake, body weight and epididymal fat mass (Figure 7).  Chronic supplementation 
also reduced blood pressure elevation in SHRSP, and FRB effectively increased serum ACE 
inhibitory activity compared to the control group (Figure 8). FRB supplementation reduced 
plasma levels of glucose and insulin (Figure 9).  FRB supplementation reduced OGTT, ITT 
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challenged glucose and insulin level, and their each area under the curve and insulin resistant 
HOMA-IR index (Figure 10). Furthermore, FRB supplementation improved serum adiponectin 
and leptin sensitivity (Figure 11). Liver lipid profiles were also significantly improved in the FRB 
experimental group (Figure 12). In the liver, glucose metabolism related hepatic gene 
expressions were suppressed to maintain glucose homeostasis in FRB treatment group. Fat 
metabolism related gene expressions (fatty acid synthase, stearyl-CoA desaturase and acetyl-
CoA carboxylase) were significantly down-regulated by FRB treatment (Figure 13). Moreover, 
nuclear transcription factors liver X receptor (LXR), sterol regulatory element binding protein-
1(SREBP-1c) and carbohydrate response element binding protein-alpha (ChREBPα) were also 
down- regulated by FRB supplementation (Figure 14). In conclusion, FRB may function as an 
effective functional food against hypertension and mitigate metabolic syndrome by regulating 
glucose, lipid, fat homeostasis, and improve serum adiponectin level in SHRSP. Thus, FRB was 
much more effective to reduce metabolic syndrome than non-fermentation component. 
 
Conclussion 
 PSM that produce bioactive peptides, can play an important role in the prevention and 
treatment of metabolic syndrome and its complications. The bioactive peptides of processed 
soymilk can activate a wide range of mechanisms including ACE inhibition and nitric oxide 
production for the prevention of hypertension. Thus the proteinase treated soymilk was useful 
to develop effective functional foods against metabolic syndrome. Furthermore, FRB was 
effective to reduce metabolic syndrome than non-fermentation component, so fermentation 
process by Aspergilus kawachii and Lactobacillus was useful to develop effective functional 
foods from food staff. New finding of this study is that the diatary consumption of PSM and FRB 
negatively regulated cardiovascular risk factors those are main component of metabolic 
syndrome in genetic animal model of hypertensive rat. PSM effectively reduced cardiovascular 
risk factors in SHR, and FRB improved hypertension, insulin resistance and hepatic glucose, lipid, 
and fat metabolism in SHRSP. Thus, PSM and FRB can be used as nonpharmacologic therapy 
component against metabolic syndrome which cause better nutrition, ideal body weight 
maintainence and body homeostasis mechanisms by dietary supplementation.  So, PSM and FRB 
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are regarded as beneficial functional foods for the prevention or treatment of life style-related 
disease.  
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メタボリックシンドロームに与える影響の解析 
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論 文 審 査 の 結 果 の 要 旨 
高血圧・糖尿病などの生活習慣病は、世界的な問題となってきており、医療
費軽減の目的から、とくに食品や食品成分による予防が重要となってきてい 
る。本研究では、高血圧・糖尿病のモデル動物となっている SHR（自然発症 
高血圧ラット）と SHRSP（脳卒中易発性高血圧自然発症ラット）を用いて、
微生物プロテアーゼ加工処理した豆乳と発酵コメ糠を用いて種々の検討を行 
った。すなわち、一つ目は細菌（Bacillus amyloliquefaciens）由来プロテア 
ーゼで豆乳を加工した加工豆乳、二つ目は共同研究者らが新規開発した  
Aspergillus oryzae と Lactobacillus を用いた風味改善発酵法による発酵コメ 
糠を用いて、生活習慣病抑制効果に関する研究を行った。 
 先ず、加工豆乳の効果について、in vivo に検討したところ、0.167 ml およ
び 0.583 ml/2 ml/ Kg 体重の１回の経口投与によって、高血圧が抑制された。
また、３週間の慢性投与によっても血圧上昇が抑制された。種々の検討の結果、
 
 
この作用機構は ACE（アンジオテンシン変換酵素）活性の抑制（実際に血漿 
アンジオテンシンⅡのレベルが有意に低下していた）と NO 産生の抑制による 
ものと推察された。この加工で生ずる FFYY などのテトラペプチドの高血圧抑 
制効果を調べたところ、降圧剤である captopril と同程度の強い高血圧抑制効 
果が確認された。 
 次に、発酵コメ糠の影響について検討したところ、この成分の 2 g/Kg 体重 
の単回経口投与で高血圧が抑制されたほかに、糖代謝も改善させることが分か 
った。さらに、４週間の慢性投与によっては、高血圧の抑制のほかに、脂肪組 
織重量の減少、ACE 活性の抑制、糖代謝を改善し、SHRSP のインスリン抵抗 
性の改善効果も認められた。この作用機構には、アディポネクティン分泌の 
改善やレプチン抵抗性の改善が関係していた。肝臓における脂質代謝・糖代謝 
の遺伝子発現レベルを調べた結果、FAS 等の脂質生合成系のダウンレギュレ 
ーションが確認されたほかに、LXR, SREBP-1c, ChREBPa などの調節因子が 
ダウンレギュレーションされており、糖質代謝の大幅改善も認められた。 
これらの新しい成果の前半部は、Journal of Functional Foods, 2015 に既に 
掲載されているほかに、後半部分は既に論文にまとめられており、投稿直前と 
なっている。当該研究者は、他の研究論文も３報持っており、益々の発展が期 
待されている。 
 よって、審査委員一同は、本研究者に博士（農学）の学位を授与するに値す 
るものと判定した。 
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